Start Date
Immediate
Expiry Date
25 Oct, 25
Salary
89700.0
Posted On
25 Jul, 25
Experience
3 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Biostatistics, Health Services Research, Epidemiology, Health Economics
Industry
Pharmaceuticals
McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well-being of you and those we serve – we care.
What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow’s health today, we want to hear from you.
JOB SUMMARY
Reporting to the Associate Director, Health Technology Assessment (HTA) and Health Economics, the Sr. Health Economist supports the development of strategic, evidence-based economic components (e.g., health economic and budget impact models and reports, and indirect treatment comparisons [ITC]) for submission to Canadian Health Technology Assessment (HTA) bodies and public/private payers.
The Sr. Health Economist will work cross-functionally with other PDCI team members, providing technical leadership on the reimbursement submission components related to indirect evidence and health economics.
MINIMUM QUALIFICATIONS
DESCRIPTION DU POSTE
Relevant du directeur associé, Évaluation des technologies de la santé (ETS) et Économie de la santé, l’économiste principal de la santé soutient le développement des composantes économiques stratégiques fondées sur des données probantes (p. ex., modèles et rapports économiques de la santé et d’impact budgétaire, comparaisons indirectes de traitements [CIT]) destinées aux organismes canadiens d’évaluation des technologies de la santé (ETS) et aux payeurs publics/privés.
L’économiste principal de la santé travaillera en collaboration avec les autres membres de l’équipe de PDCI, en assurant un leadership technique sur les éléments de soumission liés aux preuves indirectes et à l’économie de la santé.